Josh Lin
Pharmacoepidemiologist
Department of Medicine
Harvard Medical School
United States of America
Biography
Dr. Lin is a pharmacoepidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and a hospitalist at the Massachusetts General Hospital. He is an instructor at Harvard Medical school.
Research Interest
His research has been focusing on appropriate and safe prescribing in vulnerable populations and development of epidemiological and statistical solutions to combat common biases in comparative effectiveness research. Using a large electronic medical record database in the UK, The Health Improvement Network (THIN), he was among the first investigators who quantified the risk of gastrointestinal complications from taking various antithrombotic regimens and the gastroprotective effect of proton pump inhibitors and histamine-2–receptor antagonists among the users of different antithrombotic regimens.
